# NIH Prioritizes Responsible AI Governance

The National Institutes of Health (NIH) is emphasizing human oversight of AI systems to assess whether they align with human values, ethics, and mission objectives, rather than evaluating accuracy alone. NIH also supports a shared, risk-based governance framework involving government, industry, and academia. Its Bio Genesis initiative uses Department of Energy infrastructure to accelerate biomedical research, pointing to potential needs in AI governance, research computing, and biomedical data capabilities; the signal identifies no solicitation, contract value, or procurement contact.

- Contractors and technology providers working in AI governance, research computing, or biomedical data may find relevant capability areas as NIH advances these priorities, but no specific procurement opportunity is announced.
- Organizations developing AI for biomedical research should be prepared to describe how human oversight and risk-based governance support ethical, mission-aligned use—not just system accuracy.
- Bio Genesis’ use of DOE infrastructure highlights cross-agency research-computing capabilities as a potential area of relevance for firms serving NIH and DOE missions.

**Jurisdictions:** federal
**Industries:** Healthcare, Information Technology
**Topics:** Artificial Intelligence
**Published:** November 17, 2026

### Government Entities
- National Institutes of Health (NIH)
- U.S. Department of Energy (DOE)

### Sources
- [NIH Leader: AI Must Do the Right Thing, Not Just Do It Right | GovCIO Media & Research](https://govciomedia.com/nih-leader-ai-must-do-the-right-thing-not-just-do-it-right) - GovCIO Media & Research